Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2018
At a glance
- Drugs Letrozole (Primary) ; Ribociclib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms NEOLBC
- 15 May 2018 Planned initiation date changed from 1 Feb 2018 to 1 May 2018.
- 25 Apr 2018 Status changed from not yet recruiting to recruiting.
- 06 Feb 2018 Planned End Date changed from 1 Nov 2024 to 1 Feb 2025.